Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
16.13
+0.18 (1.13%)
At close: Feb 11, 2026, 4:00 PM EST
16.20
+0.07 (0.43%)
After-hours: Feb 11, 2026, 7:58 PM EST
Viatris Revenue
Viatris had revenue of $3.76B in the quarter ending September 30, 2025, with 0.23% growth. This brings the company's revenue in the last twelve months to $14.12B, down -6.14% year-over-year. In the year 2024, Viatris had annual revenue of $14.74B, down -4.46%.
Revenue (ttm)
$14.12B
Revenue Growth
-6.14%
P/S Ratio
1.35
Revenue / Employee
$441,388
Employees
32,000
Market Cap
18.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.74B | -687.60M | -4.46% |
| Dec 31, 2023 | 15.43B | -835.80M | -5.14% |
| Dec 31, 2022 | 16.26B | -1.62B | -9.08% |
| Dec 31, 2021 | 17.89B | 5.94B | 49.73% |
| Dec 31, 2020 | 11.95B | 445.50M | 3.87% |
| Dec 31, 2019 | 11.50B | 66.60M | 0.58% |
| Dec 31, 2018 | 11.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 28.48B |
| Teva Pharmaceutical Industries | 17.26B |
| Haleon | 15.10B |
| Zoetis | 9.40B |
| Elanco Animal Health | 4.59B |
| Dr. Reddy's Laboratories | 3.85B |
| United Therapeutics | 3.13B |
| Amneal Pharmaceuticals | 2.93B |
VTRS News
- 8 days ago - Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026 - PRNewsWire
- 8 days ago - Viatris Appoints Matthew J. Maletta as Chief Legal Officer - PRNewsWire
- 22 days ago - Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure - PRNewsWire
- 4 weeks ago - Viatris Inc. (VTRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer - PRNewsWire
- 5 weeks ago - Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration - GlobeNewsWire
- 7 weeks ago - Viatris Provides Pipeline Update on Four Regulatory Milestones - PRNewsWire
- 2 months ago - Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire